Christopher Bianco is a Cardiology physician affiliated with West Virginia University. OpenAlex indexes 120 publications with 1,065 citations (h-index 17).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1 Medical Center Dr
Morgantown, WV 265061200
Telephone
304-598-4000Provider last certified this registry record 8 Apr 2022.
Industry payments
13 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- E.R. Squibb & Sons, L.L.C.Program year202512 payments$15,422openpaymentsdata.cms.gov ↗
- CVRx, Inc.Program year20251 payment
- E.R. Squibb & Sons, L.L.C.Program year202412 payments$13,929openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
76.3%Beta blocker17.1%Metoprolol Succinate57%Carvedilol30%Metoprolol Tartrate9%Labetalol Hcl5%Part D<11 patientsAldosterone antagonist (MRA)14.4%Spironolactone83%Eplerenone17%Part D<11 patients+ 13 more classes in this area
Nervous system
8.7%Other nervous system drugs8.7%Vyndamax75%Vyndaqel25%Part D<11 patientsBlood & clotting
7.7%Factor Xa inhibitor6.2%Eliquis81%Xarelto19%Part D<11 patientsP2Y12 inhibitor0.8%Clopidogrel100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- The Efficacy and Safety of Levosimendan in Patients with Advanced Heart Failure: An Updated Meta-Analysis of Randomized Controlled Trials
American Journal of Cardiovascular Drugs
2024 - Call to action for drug interactions between tirzepatide and heart failure guideline-directed medical therapy
Journal of the American Pharmacists Association
2023 - Evaluation of a pharmacist-provider collaborative clinic for treatment of iron deficiency in patients with heart failure
American Journal of Health-System Pharmacy
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Ansaar Rai, MD
West Virginia University
Peter Konrad, MD, PhD
West Virginia University
Hassan Ramadan, MD
West Virginia University
Ashkan Emadi, MD, PhD
West Virginia University
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”